11/20/2025
Jay underwent his first IV treatment with IgG last week but did not tolerate it well, resulting in a three-day migraine. His doctors have recommended Hizentra as an alternative treatment. Jay’s immune system is incapable of producing sufficient antibodies (IgG), leaving him more susceptible to illness and increasing the risk of severe infections. Hizentra, an IgG replacement therapy, provides the necessary antibodies, preventing infections and maintaining his health until a transplant. Tomorrow, a nurse will visit our home to instruct me on subcutaneous administration, with the goal of minimizing side effects. Notably, Jay previously received this treatment at the age of 10, for over a year, following his diagnosis with PLE, and it built up his immune system and helped put PLE into remission. We are hoping that tomorrow's treatment won’t cause any side effects. However, if Jay experiences significant discomfort, we have informed his doctors that he will discontinue treatment and instead rely on his current regimen, while praying that his condition remains stable until a transplant can be performed.